Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Tilray Brands, Inc. is a leading player in the cannabis industry, primarily focused on the production and distribution of medical and recreational cannabis products across North America and Europe. The company operates multiple facilities, including its flagship cultivation site in Ontario, Canada, and has a growing portfolio of brands such as Tilray, Sweetwater Brewing, and Manitoba Harvest.
Tilray generates revenue through the sale of cannabis products, leveraging its extensive cultivation and processing capabilities. The company benefits from a diversified product offering and strong brand recognition in the cannabis sector, which provides pricing power in a competitive market. Additionally, its strategic partnerships and acquisitions enhance its distribution network and market reach.
Regulatory changes impacting cannabis legalization in key markets like the U.S. and Canada
Market share growth in the North American cannabis sector
Price fluctuations in cannabis products due to supply-demand dynamics
Strategic acquisitions or partnerships that enhance distribution capabilities
Ongoing regulatory uncertainty and potential changes in cannabis legislation
Market saturation in mature markets leading to price competition
Emergence of new competitors in the cannabis space, particularly from unregulated markets
Potential loss of market share to established players with stronger distribution networks
Negative operating cash flow and free cash flow could limit Tilray's ability to fund growth initiatives
High operational costs leading to sustained negative margins
moderate - The cannabis industry is somewhat insulated from economic downturns, but consumer spending on discretionary items, including cannabis products, can be impacted by economic conditions.
Higher interest rates can increase financing costs for Tilray, impacting its ability to invest in growth initiatives. Additionally, rising rates may dampen consumer spending, affecting demand for cannabis products.
minimal - Tilray's low debt-to-equity ratio (0.20) indicates limited reliance on external financing.
growth - Investors seeking exposure to the expanding cannabis market and potential for high returns from market share gains.
high - The stock has demonstrated significant price volatility, reflected in its recent performance.
